Report Detail
Global Drugs for Sinusitis Market Growth 2019-2024
- RnM2938658 |
- 13 February, 2019 |
- Global |
- 158 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks. Drugs for Sinusitis are common in the market, and the drugs can also be used in other disease. These drugs can not cure sinusitis, can only relieve symptoms.
The classification of Drugs for Sinusitis includes Antibiotics, Corticosteroids, Decongestants and other. And the revenue proportion of Corticosteroids in 2015 is nearly 31%.
Drugs for Sinusitis are widely used in Neurology, Orthopedics, Musculoskeletal &Spine, Cardiology & Vascular, Skin & Integumentary, and other field. The most proportion of Drugs for Sinusitis is Orthopedics, Musculoskeletal &Spine, and the revenue in 2015 is 2387.4 M USD.
North America region is the largest supplier of Drugs for Sinusitis, with a revenue market share nearly 35% in 2015. Europe is the second largest supplier of Drugs for Sinusitis, enjoying revenue market share nearly 27% in 2015.
North America is the largest consumption place, with a consumption market share nearly 35% in 2015. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Sanofi, Bayer AG, Pfizer etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
According to this study, over the next five years the Drugs for Sinusitis market will register a 3.6% CAGR in terms of revenue, the global market size will reach US$ 2410 million by 2024, from US$ 1950 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Drugs for Sinusitis business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Sinusitis market by product type, application, key manufacturers and key regions and countries.
This study considers the Drugs for Sinusitis value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Antibiotics
Corticosteroids
Decongestants
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Acute Sinusitis
Chronic Sinusitis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy's Laboratories
Huasun
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Drugs for Sinusitis consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Drugs for Sinusitis market by identifying its various subsegments.
Focuses on the key global Drugs for Sinusitis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for Sinusitis with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Drugs for Sinusitis submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Drugs for Sinusitis Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Drugs for Sinusitis Consumption 2014-2024
- 2.1.2 Drugs for Sinusitis Consumption CAGR by Region
- 2.2 Drugs for Sinusitis Segment by Type
- 2.2.1 Antibiotics
- 2.2.2 Corticosteroids
- 2.2.3 Decongestants
- 2.3 Drugs for Sinusitis Consumption by Type
- 2.3.1 Global Drugs for Sinusitis Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Drugs for Sinusitis Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Drugs for Sinusitis Sale Price by Type (2014-2019)
- 2.4 Drugs for Sinusitis Segment by Application
- 2.4.1 Acute Sinusitis
- 2.4.2 Chronic Sinusitis
- 2.5 Drugs for Sinusitis Consumption by Application
- 2.5.1 Global Drugs for Sinusitis Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Drugs for Sinusitis Value and Market Share by Application (2014-2019)
- 2.5.3 Global Drugs for Sinusitis Sale Price by Application (2014-2019)
3 Global Drugs for Sinusitis by Players
- 3.1 Global Drugs for Sinusitis Sales Market Share by Players
- 3.1.1 Global Drugs for Sinusitis Sales by Players (2017-2019)
- 3.1.2 Global Drugs for Sinusitis Sales Market Share by Players (2017-2019)
- 3.2 Global Drugs for Sinusitis Revenue Market Share by Players
- 3.2.1 Global Drugs for Sinusitis Revenue by Players (2017-2019)
- 3.2.2 Global Drugs for Sinusitis Revenue Market Share by Players (2017-2019)
- 3.3 Global Drugs for Sinusitis Sale Price by Players
- 3.4 Global Drugs for Sinusitis Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Drugs for Sinusitis Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Drugs for Sinusitis Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Drugs for Sinusitis by Regions
- 4.1 Drugs for Sinusitis by Regions
- 4.1.1 Global Drugs for Sinusitis Consumption by Regions
- 4.1.2 Global Drugs for Sinusitis Value by Regions
- 4.2 Americas Drugs for Sinusitis Consumption Growth
- 4.3 APAC Drugs for Sinusitis Consumption Growth
- 4.4 Europe Drugs for Sinusitis Consumption Growth
- 4.5 Middle East & Africa Drugs for Sinusitis Consumption Growth
5 Americas
- 5.1 Americas Drugs for Sinusitis Consumption by Countries
- 5.1.1 Americas Drugs for Sinusitis Consumption by Countries (2014-2019)
- 5.1.2 Americas Drugs for Sinusitis Value by Countries (2014-2019)
- 5.2 Americas Drugs for Sinusitis Consumption by Type
- 5.3 Americas Drugs for Sinusitis Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Drugs for Sinusitis Consumption by Countries
- 6.1.1 APAC Drugs for Sinusitis Consumption by Countries (2014-2019)
- 6.1.2 APAC Drugs for Sinusitis Value by Countries (2014-2019)
- 6.2 APAC Drugs for Sinusitis Consumption by Type
- 6.3 APAC Drugs for Sinusitis Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Drugs for Sinusitis by Countries
- 7.1.1 Europe Drugs for Sinusitis Consumption by Countries (2014-2019)
- 7.1.2 Europe Drugs for Sinusitis Value by Countries (2014-2019)
- 7.2 Europe Drugs for Sinusitis Consumption by Type
- 7.3 Europe Drugs for Sinusitis Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Drugs for Sinusitis by Countries
- 8.1.1 Middle East & Africa Drugs for Sinusitis Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Drugs for Sinusitis Value by Countries (2014-2019)
- 8.2 Middle East & Africa Drugs for Sinusitis Consumption by Type
- 8.3 Middle East & Africa Drugs for Sinusitis Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Drugs for Sinusitis Distributors
- 10.3 Drugs for Sinusitis Customer
11 Global Drugs for Sinusitis Market Forecast
- 11.1 Global Drugs for Sinusitis Consumption Forecast (2019-2024)
- 11.2 Global Drugs for Sinusitis Forecast by Regions
- 11.2.1 Global Drugs for Sinusitis Forecast by Regions (2019-2024)
- 11.2.2 Global Drugs for Sinusitis Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Drugs for Sinusitis Forecast by Type
- 11.8 Global Drugs for Sinusitis Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi
- 12.1.1 Company Details
- 12.1.2 Drugs for Sinusitis Product Offered
- 12.1.3 Sanofi Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi News
- 12.2 Bayer AG
- 12.2.1 Company Details
- 12.2.2 Drugs for Sinusitis Product Offered
- 12.2.3 Bayer AG Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer AG News
- 12.3 Pfizer
- 12.3.1 Company Details
- 12.3.2 Drugs for Sinusitis Product Offered
- 12.3.3 Pfizer Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Pfizer News
- 12.4 AstraZeneca Plc
- 12.4.1 Company Details
- 12.4.2 Drugs for Sinusitis Product Offered
- 12.4.3 AstraZeneca Plc Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 AstraZeneca Plc News
- 12.5 Novartis AG.
- 12.5.1 Company Details
- 12.5.2 Drugs for Sinusitis Product Offered
- 12.5.3 Novartis AG. Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Novartis AG. News
- 12.6 Johnson & Johnson
- 12.6.1 Company Details
- 12.6.2 Drugs for Sinusitis Product Offered
- 12.6.3 Johnson & Johnson Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Johnson & Johnson News
- 12.7 Merck
- 12.7.1 Company Details
- 12.7.2 Drugs for Sinusitis Product Offered
- 12.7.3 Merck Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Merck News
- 12.8 Amgen
- 12.8.1 Company Details
- 12.8.2 Drugs for Sinusitis Product Offered
- 12.8.3 Amgen Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Amgen News
- 12.9 Bionorica SE
- 12.9.1 Company Details
- 12.9.2 Drugs for Sinusitis Product Offered
- 12.9.3 Bionorica SE Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Bionorica SE News
- 12.10 Dr. Reddy's Laboratories
- 12.10.1 Company Details
- 12.10.2 Drugs for Sinusitis Product Offered
- 12.10.3 Dr. Reddy's Laboratories Drugs for Sinusitis Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Dr. Reddy's Laboratories News
- 12.11 Huasun
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Drugs for Sinusitis . Industry analysis & Market Report on Drugs for Sinusitis is a syndicated market report, published as Global Drugs for Sinusitis Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Drugs for Sinusitis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
